News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CEO of Immune Pharmaceuticals to Present at BioEquity Europe 2013


5/22/2013 9:36:52 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Immune Pharmaceuticals Ltd. (“Immune”), a privately held Israeli company, and EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced today that Daniel Teper, Chief Executive Officer of Immune, will be presenting at the BioEquity Europe 2013 conference at the Varumottagning Sheraton Hotel in Stockholm, Sweden on Thursday, May 23, at 1:30 PM local time in the St. Eriksalen Room. Dr. Teper will provide an update on the Immune/EpiCept merger and present an overview of the companies' products bertilimumab, NanomAbs, and AmiKet. The presentation will not be webcast, but the slide presentation will be available on both companies' websites."

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES